FDA Clearance Tracker · K153596
ARK Oxcarbazepine Metabolite Assay, ARK Oxcarbazepine Metabolite Calibrator, ARK Oxcarbazepine Metabolite Control
Last checked: Nov 19, 2026Latest source record: Aug 9, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Aug 9, 2016
Substantially Equivalent
Time to decision
237 days
Received Dec 16, 2015. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K153596
- Device name
- ARK Oxcarbazepine Metabolite Assay, ARK Oxcarbazepine Metabolite Calibrator, ARK Oxcarbazepine Metabolite Control
- Applicant
- Ark Diagnostics, Inc.
- Applicant location
- Fremont, CA
- Received
- Dec 16, 2015
- Decided
- Aug 9, 2016
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 862.3645
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code POX (Enzyme Immunoassay, Oxcarbazepine Metabolite).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K153596
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Ark Diagnostics, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K232522 · Decided Feb 27, 2024 · 193 days after receipt
Device type: Levetiracetam Assay (ORI) · Laboratory Medicine & Pathology
K232017 · Decided Dec 20, 2023 · 166 days after receipt
Device type: Enzyme Immunoassay, Methotrexate (LAO) · Laboratory Medicine & Pathology
- ARK Hydrocodone Assay510(k)
K231752 · Decided Nov 9, 2023 · 147 days after receipt
Device type: Enzyme Immunoassay, Opiates (DJG) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.